Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”

Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”

Article full text There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Brooks, Anne B., Langer, Jakob, Tervonen, Tommi, Hemmingsen, Mads Peter, Kosei Eguchi, Bacci, Elizabeth D.
Format: Bild
Sprache:eng
Schlagworte:
Endocrinology
FOS: Clinical medicine
Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Article full text There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
DOI:10.6084/m9.figshare.12728447